IS2370B - Nýtt forðakyrni, aðferð við framleiðslu þess og fjöleiningablanda sem inniheldur það - Google Patents

Nýtt forðakyrni, aðferð við framleiðslu þess og fjöleiningablanda sem inniheldur það

Info

Publication number
IS2370B
IS2370B IS5936A IS5936A IS2370B IS 2370 B IS2370 B IS 2370B IS 5936 A IS5936 A IS 5936A IS 5936 A IS5936 A IS 5936A IS 2370 B IS2370 B IS 2370B
Authority
IS
Iceland
Prior art keywords
polyunit
production
composition containing
new storage
storage granule
Prior art date
Application number
IS5936A
Other languages
English (en)
Other versions
IS5936A (is
Inventor
Gren Torkel
Ringberg Anders
Wikberg Martin
J. Wald Randy
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS2370(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/SE1999/001463 external-priority patent/WO2000012069A1/en
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of IS5936A publication Critical patent/IS5936A/is
Publication of IS2370B publication Critical patent/IS2370B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS5936A 1998-11-11 2001-05-09 Nýtt forðakyrni, aðferð við framleiðslu þess og fjöleiningablanda sem inniheldur það IS2370B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9803871A SE9803871D0 (sv) 1998-11-11 1998-11-11 Therapeutic method and formulation
PCT/SE1999/001463 WO2000012069A1 (en) 1998-08-27 1999-08-26 Therapeutic formulation for administering tolterodine with controlled release
PCT/SE1999/002052 WO2000027364A1 (en) 1998-11-11 1999-11-11 New controlled release bead, a method of producing the same and multiple unit formulation comprising it

Publications (2)

Publication Number Publication Date
IS5936A IS5936A (is) 2001-05-09
IS2370B true IS2370B (is) 2008-06-15

Family

ID=20413266

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5936A IS2370B (is) 1998-11-11 2001-05-09 Nýtt forðakyrni, aðferð við framleiðslu þess og fjöleiningablanda sem inniheldur það

Country Status (40)

Country Link
US (1) US6911217B1 (is)
EP (1) EP1128819B1 (is)
JP (1) JP3616011B2 (is)
KR (1) KR100467384B1 (is)
CN (1) CN1169522C (is)
AP (1) AP1323A (is)
AR (1) AR027815A1 (is)
AT (1) ATE247458T1 (is)
AU (1) AU762410B2 (is)
BG (1) BG65149B1 (is)
BR (1) BRPI9915142B8 (is)
CA (1) CA2350061C (is)
CZ (1) CZ299582B6 (is)
DE (1) DE69910604T2 (is)
DK (1) DK1128819T3 (is)
EA (1) EA005074B1 (is)
EE (1) EE05232B1 (is)
ES (1) ES2204193T3 (is)
GE (1) GEP20022833B (is)
HK (1) HK1040917B (is)
HR (1) HRP20010333B1 (is)
HU (1) HU226582B1 (is)
ID (1) ID30039A (is)
IL (1) IL142809A0 (is)
IS (1) IS2370B (is)
MA (1) MA25325A1 (is)
MY (1) MY122195A (is)
NO (1) NO331399B1 (is)
NZ (1) NZ511430A (is)
OA (1) OA11673A (is)
PL (1) PL195780B1 (is)
PT (1) PT1128819E (is)
RS (1) RS49891B (is)
SE (1) SE9803871D0 (is)
SI (1) SI1128819T1 (is)
SK (1) SK284758B6 (is)
TW (2) TWI222879B (is)
UA (1) UA57165C2 (is)
WO (1) WO2000027364A1 (is)
ZA (1) ZA200103575B (is)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003067A1 (en) * 1996-07-19 1998-01-29 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
HUP0203028A3 (en) 1999-11-11 2005-07-28 Pharmacia Ab Pharmaceutical formulation containing tolterodine and its use
US7101888B2 (en) * 2002-08-28 2006-09-05 Pharmacia & Upjohn Company Oral liquid tolterodine composition
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
MXPA05007767A (es) * 2003-01-22 2006-01-31 Pfizer Health Ab Dosis reducida de tolterodina y otros agentes antimuscarinicos para tratar trastornos urinarios.
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8709476B2 (en) 2003-11-04 2014-04-29 Supernus Pharmaceuticals, Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
DE602004030931D1 (is) 2003-11-04 2011-02-17 Supernus Pharmaceuticals Inc
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
EP1629834A1 (en) 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
JP2007527923A (ja) * 2005-01-10 2007-10-04 テバ ファーマシューティカル インダストリーズ リミティド トルテロジンタルトレートの調製方法
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
EP2997953B1 (en) 2006-01-18 2018-12-26 Intec Pharma Ltd. Delivery device for oral intake of an agent
ES2593047T3 (es) 2006-02-03 2016-12-05 Opko Renal, Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
KR100714058B1 (ko) * 2006-02-06 2007-05-02 한국유나이티드제약 주식회사 톨테로딘 엘-주석산염의 서방형 경구투여 조성물 및 이의 제조 방법
US20070202172A1 (en) * 2006-02-24 2007-08-30 Tomer Gold Metoprolol succinate E.R. tablets and methods for their preparation
CA2645940A1 (en) * 2006-03-21 2007-09-27 Teva Pharmaceutical Industries Ltd. Controlled release formulation of tolterodine
EP1839649A1 (en) * 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Coated formulations for tolterodine
JP5457830B2 (ja) * 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
EP2015735A1 (en) * 2006-04-21 2009-01-21 Synthon B.V. Tolterodine beads
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2007131804A1 (en) 2006-05-17 2007-11-22 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
ES2670029T3 (es) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
JP2008007458A (ja) * 2006-06-29 2008-01-17 Freunt Ind Co Ltd レイヤリング用核粒子とその製造方法
EP2591675A1 (en) 2006-11-27 2013-05-15 H. Lundbeck A/S Heteroaryl amide derivatives
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
US11752158B2 (en) 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
HUE073014T2 (hu) 2007-04-25 2025-12-28 Opko Renal Llc Eljárás a másodlagos hyperparathyreoidismus biztonságos és hatékony kezelésére és megelõzésére krónikus vesebetegség esetén
KR20190028822A (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
CL2008001970A1 (es) * 2007-07-03 2009-03-27 Synthon Bv Perla con un nucleo de celulosa microcristalina, un recubrimiento soluble en agua con un polimero vinil pirrolidina, una capa con tolterodina y un aglutinante, y una capa de liberacion controlada con un poliacrilato; proceso para prepararla; forma de dosificacion, util en trastornos urinarios como vejiga hiperactiva.
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
US8486452B2 (en) 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
EP2175843B1 (en) * 2007-08-08 2014-10-08 Inventia Healthcare Private Limited Extended release compositions comprising tolterodine
AU2008286914B2 (en) * 2007-08-13 2014-10-02 Ohemo Life Sciences Inc. Abuse resistant drugs, method of use and method of making
US20090192228A1 (en) * 2008-01-28 2009-07-30 Actavis Group Ptc Ehf Controlled-Release Tolterodine Compositions and Methods
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
CA2629099A1 (en) * 2008-04-01 2009-10-01 Pharmascience Inc. Novel oral controlled release pharmaceutical formulations
EP2281058B1 (en) 2008-04-02 2016-06-29 Opko Ireland Global Holdings, Ltd. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
WO2009140557A2 (en) * 2008-05-14 2009-11-19 Capricorn Pharma, Inc. Modified release tolterodine formulations
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8465770B2 (en) 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
US9078830B2 (en) 2009-07-31 2015-07-14 Ranbaxy Laboratories Limited Multi-layered, multiple unit pharmaceutical compositions
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011061616A2 (en) 2009-11-23 2011-05-26 Micro Labs Limited Extended release compositions containing tolterodine and process for preparing the same
WO2011095388A1 (en) 2010-02-04 2011-08-11 Synthon Bv Tolterodine bead
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
NZ706991A (en) 2010-03-29 2016-08-26 Ferring Bv A fast dissolving pharmaceutical composition
WO2011123476A1 (en) 2010-03-29 2011-10-06 Cytochroma Inc. Methods and compositions for reducing parathyroid levels
WO2011137054A1 (en) 2010-04-30 2011-11-03 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120289560A1 (en) * 2011-05-10 2012-11-15 Theravida, Inc. Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
GR1007628B (el) 2011-07-27 2012-06-29 Φαρματεν Αβεε, Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου
RU2633640C2 (ru) 2011-09-16 2017-10-16 Ферринг Б.В. Быстрорастворимая фармацевтическая композиция
WO2013047795A1 (ja) * 2011-09-30 2013-04-04 アステラス製薬株式会社 粒子状医薬組成物
CA2878784A1 (en) 2012-07-12 2014-01-16 Ferring B.V. Diclofenac formulations
JP2015529255A (ja) * 2012-09-20 2015-10-05 オーエイチアール ファーマ， エルエルシーＯｈｒ Ｐｈａｒｍａ， Ｌｌｃ 治療薬の持続放出のための多層の生体分解可能なマイクロ粒子
TW201422254A (zh) 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release
WO2014159051A1 (en) * 2013-03-13 2014-10-02 Advanced Bionutrition Corp. Stable bioactive substances and methods of making
US20140275149A1 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
AU2014246617A1 (en) 2013-12-23 2015-07-09 Sun Pharmaceutical Industries Limited Multi-layered, multiple unit pharmaceutical compositions
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
CA2936740C (en) * 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
JP6924177B2 (ja) * 2016-02-23 2021-08-25 ニプロ株式会社 医薬組成物粒子とそれを含む口腔内崩壊製剤
JP7032322B2 (ja) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド ビタミンｄ治療法
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPH07107450A (ja) 1993-10-08 1995-04-21 Hitachi Ltd 情報通信装置
JP3453186B2 (ja) 1994-04-14 2003-10-06 共和薬品工業株式会社 徐放性マイクロカプセルおよびその製造方法
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
US5645858A (en) * 1994-10-06 1997-07-08 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
WO1998003067A1 (en) 1996-07-19 1998-01-29 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation

Also Published As

Publication number Publication date
NZ511430A (en) 2003-05-30
HRP20010333A2 (en) 2003-04-30
BR9915142A (pt) 2001-08-07
ATE247458T1 (de) 2003-09-15
BG65149B1 (bg) 2007-04-30
SK6252001A3 (en) 2002-01-07
SE9803871D0 (sv) 1998-11-11
HRP20010333B1 (en) 2004-10-31
CN1169522C (zh) 2004-10-06
CZ299582B6 (cs) 2008-09-10
BRPI9915142B1 (pt) 2015-08-25
TWI222879B (en) 2004-11-01
HU226582B1 (en) 2009-04-28
HUP0105038A2 (en) 2002-06-29
OA11673A (en) 2005-01-12
IL142809A0 (en) 2002-03-10
HK1040917B (zh) 2005-05-27
BG105582A (en) 2001-12-29
EE200100254A (et) 2002-12-16
UA57165C2 (uk) 2003-06-16
TWI267385B (en) 2006-12-01
DE69910604T2 (de) 2004-06-24
MY122195A (en) 2006-03-31
ES2204193T3 (es) 2004-04-16
US6911217B1 (en) 2005-06-28
AR027815A1 (es) 2003-04-16
KR100467384B1 (ko) 2005-01-24
CA2350061C (en) 2005-05-17
AP2001002166A0 (en) 2001-06-30
SI1128819T1 (en) 2003-12-31
WO2000027364A1 (en) 2000-05-18
PL348612A1 (en) 2002-06-03
YU33101A (sh) 2003-10-31
AU1436600A (en) 2000-05-29
HUP0105038A3 (en) 2006-07-28
EP1128819B1 (en) 2003-08-20
GEP20022833B (en) 2002-11-25
HK1040917A1 (en) 2002-06-28
EA005074B1 (ru) 2004-10-28
EP1128819A1 (en) 2001-09-05
NO331399B1 (no) 2011-12-19
CZ20011627A3 (cs) 2001-10-17
CN1326339A (zh) 2001-12-12
EA200100538A1 (ru) 2001-10-22
JP2003517446A (ja) 2003-05-27
EE05232B1 (et) 2009-12-15
ID30039A (id) 2001-11-01
BRPI9915142B8 (pt) 2021-05-25
SK284758B6 (sk) 2005-11-03
CA2350061A1 (en) 2000-05-18
RS49891B (sr) 2008-08-07
ZA200103575B (en) 2002-05-03
DK1128819T3 (da) 2003-12-01
PT1128819E (pt) 2003-12-31
MA25325A1 (fr) 2001-12-31
AP1323A (en) 2004-11-05
NO20012314L (no) 2001-07-09
DE69910604D1 (de) 2003-09-25
JP3616011B2 (ja) 2005-02-02
IS5936A (is) 2001-05-09
KR20010075695A (ko) 2001-08-09
NO20012314D0 (no) 2001-05-10
AU762410B2 (en) 2003-06-26
PL195780B1 (pl) 2007-10-31

Similar Documents

Publication Publication Date Title
IS2370B (is) Nýtt forðakyrni, aðferð við framleiðslu þess og fjöleiningablanda sem inniheldur það
IL136951A0 (en) Sustained-release composition, method of its production and use thereof
DE19981724D2 (de) Nikotinhaltige Kaumasse und deren Herstellungsverfahren
IL147246A0 (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same
PL348324A1 (en) Electrolyte-coated permeable compound material, method of obtaining same and application thereof
IL138676A0 (en) Substituted benzamides, their production and their use as cysteine protease inhibitors
IS2040B (is) Pýrasólínafleiður, framleiðsla þeirra og notkun sem lyfja
ATE466485T1 (de) Lebensmittel enthaltend eine gelzusammensetzung sowie herstellungsverfahren
PL343465A1 (en) New substituted amides, their production and their use
GB2391549B (en) Porous film and its production process
EP1090566A4 (en) TOOTHBRUSH AND MANUFACTURING METHOD
EP1199382A4 (en) HOLES STRUCTURE AND MANUFACTURING PROCEDURE
EP1367541A4 (en) ANIMATION PLAYER, ANIMATION PLAYBACK METHOD AND ITS PROGRAM
MXPA01013412A (es) Composiciones de citrato de calcio potasico y metodos de produccion.
EG22592A (en) Coated fertilizer composition and method for its production
GB2343450B (en) Trimethylcyclohexenylcyclopropyl ketones, methods of their production and uses thereof
IL136950A0 (en) Heterocyclic compounds, their production and use
NO20001909D0 (no) Fremgangsmõte og anlegg for fremstilling av 1,2-dikloretan
NO20013830L (no) Pulverbelagt strimmel og fremgangsmåte for fremstilling av samme
ID27412A (id) Proses pembuatan urea
AU4439999A (en) Metal yo-yo and method for manufacture
ZA200005540B (en) New hydroxyindoles, their use as phosphodiestrase 4 inhibitors and method for producing same.
AU6222901A (en) Cyclipostins, a method for their production and the use of the same
IL152795A0 (en) Method for the production of 2-coumarone and substituted 2-coumarones
HUP0104950A3 (en) Composition containing glycerol trinitrate, method for producing said composition and use of the same